GoldenGolden
Exosome Diagnostics

Exosome Diagnostics

A company developing and commercializing cancer molecular diagnostics based isolation of exosomes from body fluids. Exosome Diagnostics was founded in 2008.

Exosome Diagnostics isolates exosomes, cell-derived vesicles, which contain RNA, DNA and proteins, from serum, plasma, urine, cerebralspinal fluid and saliva. The company performs molecular analysis of exosomes for diagnotics, disease detection, treatment and monitoring. Exosome Diagnostics collaborates with pharmaceutical companies such as Amgen and Takeda in research and development, biomarker discovery, validation and development of diagnostics.

While Chief Scientific Officer Johan Skog was at Massachusetts General Hospital, he was the first to demonstrate the detection of molecular mutations in a tumor in RNA extracted from exosomes in Nature Cell Biology in 2008.

Timeline

March 2014
Exosome Diagnostics raises a $27,000,000 series B round from Arcus Ventures, CD-Venture, Forbion Capital Partners, Monashee Capital Corp, NGN Capital, Qiagen and Tiger Management Corp..
June 11, 2013
Exosome Diagnostics raises a $6,500,000 series B round.
May 11, 2010
Exosome Diagnostics raises a $20,000,000 series A round from Forbion Capital Partners.
2008
Exosome Diagnostics was founded by James R. McCullough and Shelly Hirshon.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Exosome Diagnostics Series B round March 2014
27,000,000
March 2014
3 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Johan Skog

Founding Scientist, CSO

John Healy

Employee

Mikkel Noerholm, PhD

VP Product Development

Thomas McLain, MBA, CPA

General Manager

William J. Kelly, CPA

CFO

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Bio-Techne Corporation
March 8, 2021
www.prnewswire.com:443
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has published preliminary data on its...
Bio-Techne Corporation
February 11, 2021
www.prnewswire.com:443
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has recently published a paper entitled...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.